dimethadione has been researched along with Liver Dysfunction in 3 studies
Dimethadione: An anticonvulsant that is the active metabolite of TRIMETHADIONE.
Excerpt | Relevance | Reference |
---|---|---|
"Trimethadione (TMO) has the properties required of probe drugs for the evaluation of hepatic drug-oxidizing capacity in humans in vivo." | 2.39 | Trimethadione as a probe drug to estimate hepatic oxidizing capacity in humans. ( Abei, M; Ishikawa, A; Kobayashi, S; Tanaka, E, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tanaka, E | 3 |
Funae, Y | 1 |
Ishikawa, A | 2 |
Abei, M | 1 |
Kobayashi, S | 1 |
Ono, A | 1 |
Okamura, T | 1 |
Misawa, S | 1 |
1 review available for dimethadione and Liver Dysfunction
Article | Year |
---|---|
Trimethadione as a probe drug to estimate hepatic oxidizing capacity in humans.
Topics: Administration, Oral; Animals; Clinical Trials as Topic; Dimethadione; Humans; Liver Diseases; Micro | 1996 |
2 other studies available for dimethadione and Liver Dysfunction
Article | Year |
---|---|
Trimethadione: metabolism and assessment of hepatic drug-oxidizing capacity.
Topics: Animals; Anticonvulsants; Chromatography, Gas; Dimethadione; Humans; In Vitro Techniques; Liver; Liv | 1996 |
Trimethadione metabolism in patients with normal liver and in patients with chronic liver disease.
Topics: Carcinoma, Hepatocellular; Chronic Disease; Dimethadione; Female; Humans; Liver Cirrhosis; Liver Dis | 1987 |